Skip to main content
Top
Published in: Diabetologia 12/2006

01-12-2006 | Article

Vascular depression in older people with diabetes

Authors: D. G. Bruce, G. Casey, W. A. Davis, S. E. Starkstein, R. C. Clarnette, J. K. Foster, F. J. Ives, O. P. Almeida, T. M. E. Davis

Published in: Diabetologia | Issue 12/2006

Login to get access

Abstract

Aims/hypothesis

Cerebrovascular disease may be causal or a vulnerability factor in late-onset depression and may explain the high rate of depression in older adults with diabetes. We explored a wide range of potential explanatory variables of depression in a longitudinal study of older diabetic subjects to investigate the vascular depression hypothesis in these patients.

Methods

We recruited 207 subjects with diabetes selected for potential cognitive deficits from an existing observational cohort study (average age 75.7 ± 4.6 years, 52.2% men) for an assessment of depression using a standardised diagnostic instrument (Cambridge Examination for Mental Disorders of the Elderly — Revised). All subjects underwent a detailed clinical assessment at baseline and at follow-up (after 7.5 ± 1.1 years).

Results

Major depression was present in 45 subjects (21.7%) and minor depression in ten (4.8%). A positive history of strokes and the presence of peripheral arterial disease were significantly associated with depression at the time of diagnosis. In a subsample of 93 cases who underwent structural neuroimaging, the presence of cerebral infarcts was also significantly associated with depression. Treatment with glucose-lowering therapy, higher serum cholesterol levels and difficulties with activities of daily living at baseline were significant predictors of depression at follow-up.

Conclusions/interpretation

A history of cerebrovascular disease was strongly associated with depression and cerebrovascular risk factors were significant predictors of depression in older diabetic patients. Our findings are consistent with the hypothesis that the excess risk of depression in older diabetic patients is related to underlying cerebrovascular disease.
Literature
1.
go back to reference Gavard J, Lustman P, Clouse RER (1993) Prevalence of depression in adults with diabetes. Diabetes Care 16:1167–1178PubMed Gavard J, Lustman P, Clouse RER (1993) Prevalence of depression in adults with diabetes. Diabetes Care 16:1167–1178PubMed
2.
go back to reference Eaton WE (2002) Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 53:903–906PubMedCrossRef Eaton WE (2002) Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res 53:903–906PubMedCrossRef
3.
go back to reference Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078PubMed Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078PubMed
4.
go back to reference Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26:2822–2828PubMed Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26:2822–2828PubMed
5.
go back to reference Bruce DG, Davis WA, Starkstein SE, Davis TME (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539PubMedCrossRef Bruce DG, Davis WA, Starkstein SE, Davis TME (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539PubMedCrossRef
6.
go back to reference Egede LE, Zheng D (2003) Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 26:104–111PubMed Egede LE, Zheng D (2003) Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 26:104–111PubMed
7.
go back to reference Bell RA, Smith SL, Arcury TA, Snivelly BM, Stafford J, Quande SA (2005) Prevalence and correlates of depressive symptoms among rural older African Americans, native Americans and whites with diabetes. Diabetes Care 28:823–829PubMed Bell RA, Smith SL, Arcury TA, Snivelly BM, Stafford J, Quande SA (2005) Prevalence and correlates of depressive symptoms among rural older African Americans, native Americans and whites with diabetes. Diabetes Care 28:823–829PubMed
8.
go back to reference Bruce DG, Casey GP, Grange V et al (2003) Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes study. Diabetes Res Clin Pract 61:59–67PubMedCrossRef Bruce DG, Casey GP, Grange V et al (2003) Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes study. Diabetes Res Clin Pract 61:59–67PubMedCrossRef
9.
go back to reference Lin EH, Katon W, Von Korff M et al (2004) Relationship of depression and diabetes self-care, medication adherence and preventive care. Diabetes Care 27:2154–2160PubMed Lin EH, Katon W, Von Korff M et al (2004) Relationship of depression and diabetes self-care, medication adherence and preventive care. Diabetes Care 27:2154–2160PubMed
10.
go back to reference Checkley S (1996) The neuroendocrinology of depression and chronic stress. Br Med Bull 52:597–617PubMed Checkley S (1996) The neuroendocrinology of depression and chronic stress. Br Med Bull 52:597–617PubMed
11.
go back to reference Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113:472–474PubMedCrossRef Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113:472–474PubMedCrossRef
12.
go back to reference Krishnan KRR, Hays JC, Blazer DG (1997) MRI-defined vascular depression. Am J Psychiatry 154:497–500PubMed Krishnan KRR, Hays JC, Blazer DG (1997) MRI-defined vascular depression. Am J Psychiatry 154:497–500PubMed
13.
go back to reference Alexopoulos GS, Meyers BS, Young RC, Campbell S, Sibersweig D, Charlson M (1997) The “vascular depression” hypothesis. Arch Gen Psych 54:15–22 Alexopoulos GS, Meyers BS, Young RC, Campbell S, Sibersweig D, Charlson M (1997) The “vascular depression” hypothesis. Arch Gen Psych 54:15–22
14.
go back to reference Robinson RG (2003) Poststroke depression: prevalence, diagnosis, treatment and disease prevention. Biol Psychiatry 54:376–387PubMedCrossRef Robinson RG (2003) Poststroke depression: prevalence, diagnosis, treatment and disease prevention. Biol Psychiatry 54:376–387PubMedCrossRef
15.
go back to reference Loug S, Melamed E, Cahane E, Carmen A (1973) Hypertension and diabetes as risk factors in stroke patients. Stroke 4:751–759 Loug S, Melamed E, Cahane E, Carmen A (1973) Hypertension and diabetes as risk factors in stroke patients. Stroke 4:751–759
16.
go back to reference Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M (1997) Clinically defined vascular depression. Am J Psychiatry 154:562–565PubMed Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M (1997) Clinically defined vascular depression. Am J Psychiatry 154:562–565PubMed
17.
go back to reference De Groot M, Anderson R, Freedland KL, Clouse RE, Lustmnan PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630PubMed De Groot M, Anderson R, Freedland KL, Clouse RE, Lustmnan PJ (2001) Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630PubMed
18.
go back to reference Lavretsky H, Kumar A (2002) Clinically significant non-major depression. Old concepts, new insights. Am J Geriatr Psychiatry 10:239–255PubMedCrossRef Lavretsky H, Kumar A (2002) Clinically significant non-major depression. Old concepts, new insights. Am J Geriatr Psychiatry 10:239–255PubMedCrossRef
19.
go back to reference Blazer DG (2003) Depression in late life: review and commentary. J Gerontol Med Sci 56A:249–265 Blazer DG (2003) Depression in late life: review and commentary. J Gerontol Med Sci 56A:249–265
20.
go back to reference Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674PubMedCrossRef Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674PubMedCrossRef
21.
go back to reference Bruce DG, Davis WA, Davis TME (2000) Glycemic control in older diabetic patients in the Fremantle Diabetes Study. J Am Geriatr Soc 48:1449–1453PubMed Bruce DG, Davis WA, Davis TME (2000) Glycemic control in older diabetic patients in the Fremantle Diabetes Study. J Am Geriatr Soc 48:1449–1453PubMed
22.
go back to reference Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes — systematic overview of prospective observational studies. Diabetologia 48:2460–2469PubMedCrossRef Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes — systematic overview of prospective observational studies. Diabetologia 48:2460–2469PubMedCrossRef
23.
go back to reference Davis TME, Davis W, Mulder JW, Fortune P, Bruce DG (2004) Silent myocardial infarction and its prognosis in a community-based cohort of diabetic patients: the Fremantle Diabetes Study. Diabetologia 47:395–399PubMedCrossRef Davis TME, Davis W, Mulder JW, Fortune P, Bruce DG (2004) Silent myocardial infarction and its prognosis in a community-based cohort of diabetic patients: the Fremantle Diabetes Study. Diabetologia 47:395–399PubMedCrossRef
24.
go back to reference Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289PubMed Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289PubMed
25.
go back to reference Davis WA, Knuiman MW, Hendrie D, Davis TME (2005) Determinants of diabetes-attributable non-blood glucose-lowering medication costs for type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 28:329–336PubMed Davis WA, Knuiman MW, Hendrie D, Davis TME (2005) Determinants of diabetes-attributable non-blood glucose-lowering medication costs for type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 28:329–336PubMed
26.
go back to reference Norman PE, Davis WA, Bruce DG, Davis TME (2006) Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 29:575–580PubMedCrossRef Norman PE, Davis WA, Bruce DG, Davis TME (2006) Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 29:575–580PubMedCrossRef
27.
go back to reference Gudex C, Kind P (1989) The QALY toolkit. Centre for Health Economics, University of York, York Gudex C, Kind P (1989) The QALY toolkit. Centre for Health Economics, University of York, York
28.
go back to reference Bruce DG, Davis WA, Davis TME (2005) Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes mellitus: the Fremantle Diabetes Study. Diabetes Care 28:2441–2447PubMed Bruce DG, Davis WA, Davis TME (2005) Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes mellitus: the Fremantle Diabetes Study. Diabetes Care 28:2441–2447PubMed
29.
go back to reference Folstein M, Folstein S, McHugh PR (1975) Mini-mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein M, Folstein S, McHugh PR (1975) Mini-mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
30.
go back to reference Jorm AF (1994) A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 24:145–153PubMedCrossRef Jorm AF (1994) A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 24:145–153PubMedCrossRef
31.
go back to reference Roth M, Tym E, Mountjoy CQ et al (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698–709PubMedCrossRef Roth M, Tym E, Mountjoy CQ et al (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698–709PubMedCrossRef
32.
go back to reference Neri M, Andermarcher E, Spano A et al (1992) Validation study of the Italian version of the Cambridge Mental Disorders of the Elderly Examination: preliminary findings. Dementia 3:70–77 Neri M, Andermarcher E, Spano A et al (1992) Validation study of the Italian version of the Cambridge Mental Disorders of the Elderly Examination: preliminary findings. Dementia 3:70–77
33.
go back to reference Girling DM, Barkley C, Paykel ES et al (1995) The prevalence of depression in a cohort of the very elderly. J Affect Dis 34:319–329PubMedCrossRef Girling DM, Barkley C, Paykel ES et al (1995) The prevalence of depression in a cohort of the very elderly. J Affect Dis 34:319–329PubMedCrossRef
34.
go back to reference Benedict RHB (1997) Brief visual memory test — revised. Psychological Assessment Resources, Inc, Odessa, FL Benedict RHB (1997) Brief visual memory test — revised. Psychological Assessment Resources, Inc, Odessa, FL
35.
go back to reference Wechsler D (1997) Wechsler memory scale, Third edn. Psychological Corporation, New York Wechsler D (1997) Wechsler memory scale, Third edn. Psychological Corporation, New York
36.
go back to reference Wechsler D (1997) Wechsler adult intelligence scale, III edn. Psychological Corporation, San Antonio Wechsler D (1997) Wechsler adult intelligence scale, III edn. Psychological Corporation, San Antonio
37.
go back to reference Spreen O, Benton AL (1977) Manual of instructions. Neurosensory center comprehensive examination for aphasia. 1977 Revision. University of Victoria, Victoria, BC Spreen O, Benton AL (1977) Manual of instructions. Neurosensory center comprehensive examination for aphasia. 1977 Revision. University of Victoria, Victoria, BC
38.
go back to reference Palsson S, Skoog I (1997) The epidemiology of affective disorders in the elderly: a review. Int Clin Psychopharmacol 12:S3–S13PubMedCrossRef Palsson S, Skoog I (1997) The epidemiology of affective disorders in the elderly: a review. Int Clin Psychopharmacol 12:S3–S13PubMedCrossRef
39.
go back to reference Beekman ATF, Copeland JRM, Prince MJ (1999) Review of community prevalence of depression in late life. Br J Psychiatr 174:307–311CrossRef Beekman ATF, Copeland JRM, Prince MJ (1999) Review of community prevalence of depression in late life. Br J Psychiatr 174:307–311CrossRef
40.
go back to reference Kissela BM, Khouri J, Kleindorfer D et al (2005) Epidemiology of ischemic stroke in patients with diabetes: the Greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28:355–359PubMed Kissela BM, Khouri J, Kleindorfer D et al (2005) Epidemiology of ischemic stroke in patients with diabetes: the Greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care 28:355–359PubMed
41.
go back to reference Davis TME, Davis WA, Bruce DG (2006) Glycaemic levels triggering therapeutic intensification in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Aust 184:325–328PubMed Davis TME, Davis WA, Bruce DG (2006) Glycaemic levels triggering therapeutic intensification in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Aust 184:325–328PubMed
42.
go back to reference Amarenco P, Labreuche J, Lavalee P, Touboul P-J (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35:2902–2909PubMedCrossRef Amarenco P, Labreuche J, Lavalee P, Touboul P-J (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35:2902–2909PubMedCrossRef
44.
go back to reference Camus V, Kraehenbuhl H, Preisig M, Bula CJ, Waeber G (2004) Geriatric depression and vascular diseases: what are the links? J Affect Dis 81:1–16PubMedCrossRef Camus V, Kraehenbuhl H, Preisig M, Bula CJ, Waeber G (2004) Geriatric depression and vascular diseases: what are the links? J Affect Dis 81:1–16PubMedCrossRef
45.
go back to reference Arseven A, Guralnik JM, Liu K, McDermott MM (2001) Peripheral arterial disease and depressed mood in older men and women. Vasc Med 6:229–234PubMed Arseven A, Guralnik JM, Liu K, McDermott MM (2001) Peripheral arterial disease and depressed mood in older men and women. Vasc Med 6:229–234PubMed
46.
go back to reference Wattanakit K, Williams JE, Schreiner PJ, Hirsch AT, Folsom AR (2005) Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study. Vasc Med 10:199–206PubMedCrossRef Wattanakit K, Williams JE, Schreiner PJ, Hirsch AT, Folsom AR (2005) Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study. Vasc Med 10:199–206PubMedCrossRef
47.
go back to reference Rothwell PM, Coull AJ, Silver LE et al (2005) Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366:1773–1783PubMedCrossRef Rothwell PM, Coull AJ, Silver LE et al (2005) Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366:1773–1783PubMedCrossRef
48.
go back to reference Doobay AV, Anand SS (2005) Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 25:1463–1469PubMedCrossRef Doobay AV, Anand SS (2005) Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 25:1463–1469PubMedCrossRef
49.
go back to reference Williams J, Katon W, Lim EHB et al (2004) Effectiveness of depression care management for older adults with coexisting depression and diabetes mellitus. Ann Int Med 140:1015–1024PubMed Williams J, Katon W, Lim EHB et al (2004) Effectiveness of depression care management for older adults with coexisting depression and diabetes mellitus. Ann Int Med 140:1015–1024PubMed
Metadata
Title
Vascular depression in older people with diabetes
Authors
D. G. Bruce
G. Casey
W. A. Davis
S. E. Starkstein
R. C. Clarnette
J. K. Foster
F. J. Ives
O. P. Almeida
T. M. E. Davis
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0478-y

Other articles of this Issue 12/2006

Diabetologia 12/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.